Name: PHA-665752
Brand: Selleck Chemicals
SKU: S1070
Availability: InStock
Rating: 5 (97 reviews)

Jump to

Quality Control

Batch: Purity: 99.91%

99.91

Related Targets	EGFR VEGFR PDGFR FGFR Src MEK CSF-1R FLT3 HER2 c-Kit
Other c-Met Inhibitors	Tepotinib Dihexa SGX-523 Foretinib SU11274 BMS-777607 JNJ-38877605 Tivantinib PF-04217903 Savolitinib (AZD6094)

Cell Culture, Treatment & Working Concentration

Cell Lines	Assay Type	Activity Description
NCI-SNU-5	Growth Inhibition Assay	IC50=0.12375 μM
LB2241-RCC	Growth Inhibition Assay	IC50=0.15702 μM
KINGS-1	Growth Inhibition Assay	IC50=0.35911 μM
ALL-PO	Growth Inhibition Assay	IC50=0.81277 μM
SK-LMS-1	Growth Inhibition Assay	IC50=0.89846 μM
MV-4-11	Growth Inhibition Assay	IC50=1.2947 μM
SUP-T1	Growth Inhibition Assay	IC50=2.13964 μM
MRK-nu-1	Growth Inhibition Assay	IC50=2.40056 μM
ES1	Growth Inhibition Assay	IC50=3.34866 μM
NOS-1	Growth Inhibition Assay	IC50=4.39867 μM
KM12	Growth Inhibition Assay	IC50=4.418 μM
Becker	Growth Inhibition Assay	IC50=5.2466 μM
NCI-SNU-1	Growth Inhibition Assay	IC50=5.63733 μM
EW-22	Growth Inhibition Assay	IC50=7.73614 μM
ES6	Growth Inhibition Assay	IC50=7.8195 μM
A498	Growth Inhibition Assay	IC50=8.28446 μM
EW-16	Growth Inhibition Assay	IC50=9.6543 μM
CTV-1	Growth Inhibition Assay	IC50=9.85024 μM
ETK-1	Growth Inhibition Assay	IC50=10.2931 μM
NCI-H1395	Growth Inhibition Assay	IC50=10.8024 μM
DOHH-2	Growth Inhibition Assay	IC50=10.9264 μM
GI-1	Growth Inhibition Assay	IC50=11.8596 μM
HT-144	Growth Inhibition Assay	IC50=14.2163 μM
ES5	Growth Inhibition Assay	IC50=14.467 μM
NALM-6	Growth Inhibition Assay	IC50=15.2196 μM
KNS-81-FD	Growth Inhibition Assay	IC50=15.5849 μM
TE-15	Growth Inhibition Assay	IC50=16.5771 μM
SCC-15	Growth Inhibition Assay	IC50=18.3498 μM
EoL-1-cell	Growth Inhibition Assay	IC50=18.4545 μM
NCI-H720	Growth Inhibition Assay	IC50=18.771 μM
NB14	Growth Inhibition Assay	IC50=19.5425 μM
KE-37	Growth Inhibition Assay	IC50=19.8233 μM
LXF-289	Growth Inhibition Assay	IC50=19.8629 μM
RPMI-8402	Growth Inhibition Assay	IC50=20.3269 μM
SK-N-DZ	Growth Inhibition Assay	IC50=21.2131 μM
ACN	Growth Inhibition Assay	IC50=22.2497 μM
TE-11	Growth Inhibition Assay	IC50=26.069 μM
COLO-800	Growth Inhibition Assay	IC50=27.17 μM
MOLT-13	Growth Inhibition Assay	IC50=27.1847 μM
697	Growth Inhibition Assay	IC50=28.7633 μM
VA-ES-BJ	Growth Inhibition Assay	IC50=29.3729 μM
EW-13	Growth Inhibition Assay	IC50=29.5045 μM
NB7	Growth Inhibition Assay	IC50=32.2665 μM
MONO-MAC-6	Growth Inhibition Assay	IC50=32.8795 μM
SW962	Growth Inhibition Assay	IC50=33.4513 μM
KS-1	Growth Inhibition Assay	IC50=33.9481 μM
KU812	Growth Inhibition Assay	IC50=34.5702 μM
IMR-5	Growth Inhibition Assay	IC50=37.4318 μM
BC-1	Growth Inhibition Assay	IC50=38.033 μM
NCI-H510A	Growth Inhibition Assay	IC50=38.2032 μM
EW-18	Growth Inhibition Assay	IC50=40.8303 μM
CCRF-CEM	Growth Inhibition Assay	IC50=42.2797 μM
HH	Growth Inhibition Assay	IC50=43.5069 μM
NCI-H2171	Growth Inhibition Assay	IC50=46.0272 μM
LC-2-ad	Growth Inhibition Assay	IC50=49.1413 μM
Click to View More Cell Line Experimental Data

Solubility

In vitro
Batch:

DMSO : 128 mg/mL (199.49 mM)
(Moisture-contaminated DMSO may reduce solubility. Use fresh, anhydrous DMSO.)

Ethanol : 10 mg/mL

Water : Insoluble

Molarity Calculator

Mass	Concentration	Volume	Molecular Weight
Mass value Mass unit	Concentration value Concentration unit	Volume value Volume unit	Molecular weight (g/mol)

Dilution Calculator Molecular Weight Calculator

In vivo batch selection In vivo Batch:
Homogeneous suspension	CMC-NA	≥5mg/ml	Taking the 1 mL working solution as an example, add 5 mg of this product to 1 ml of CMC-Na solution, mix evenly to obtain a homogeneous suspension with a final concentration of 5 mg/ml.
Homogeneous suspension	CMC-NA	≥5mg/ml	Taking the 1 mL working solution as an example, add 5 mg of this product to 1 ml of CMC-Na solution, mix evenly to obtain a homogeneous suspension with a final concentration of 5 mg/ml.
Homogeneous suspension	CMC-NA	≥5mg/ml	Taking the 1 mL working solution as an example, add 5 mg of this product to 1 ml of CMC-Na solution, mix evenly to obtain a homogeneous suspension with a final concentration of 5 mg/ml.
Homogeneous suspension	CMC-NA	≥5mg/ml	Taking the 1 mL working solution as an example, add 5 mg of this product to 1 ml of CMC-Na solution, mix evenly to obtain a homogeneous suspension with a final concentration of 5 mg/ml.
Clear solution	5% DMSO 1 95% corn oil Validated by Selleck labs. Should you need adjustments to this formulation, contact our sales team for custom testing.	0.460mg/ml (0.72mM)	Taking the 1 mL working solution as an example, add 50 μL of clarified DMSO stock solution of 9.2 mg/ml to 950 μL of corn oil, mix evenly to clarify it, and prepare the working solution for immediate use!
Homogeneous suspension	CMC-NA	≥5mg/ml	Taking the 1 mL working solution as an example, add 5 mg of this product to 1 ml of CMC-Na solution, mix evenly to obtain a homogeneous suspension with a final concentration of 5 mg/ml.

In vivo Formulation Calculator (Clear solution)

Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)

Dosage: mg/kg

Average weight of animals: g

Dosing volume per animal: μL

Number of animals:

Step 2: Enter the in vivo formulation (This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)

% DMSO

%

% Tween 80

% ddH₂O

% DMSO

+

%

Calculation results:

Working concentration: mg/ml;

Method for preparing DMSO master liquid: mg drug pre-dissolved in μL DMSO ( Master liquid concentration mg/mL, Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug. )

Method for preparing in vivo formulation: Take μL DMSO master liquid, next addμL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH₂O, mix and clarify.

Method for preparing in vivo formulation: Take μL DMSO master liquid, next add μL Corn oil, mix and clarify.

Note: 1. Please make sure the liquid is clear before adding the next solvent.
2. Be sure to add the solvent(s) in order. You must ensure that the solution obtained, in the previous addition, is a clear solution before proceeding to add the next solvent. Physical methods such
as vortex, ultrasound or hot water bath can be used to aid dissolving.

Chemical Information, Storage & Stability

Molecular Weight	641.61	Formula	C₃₂H₃₄Cl₂N₄O₄S	Storage (From the date of receipt)	3 years-20°Cpowder
CAS No.	477575-56-7	Download SDF		Storage of Stock Solutions	1 year-80°Cin solvent 1 month-20°Cin solvent
Synonyms	N/A			Smiles	CC1=C(NC(=C1C(=O)N2CCCC2CN3CCCC3)C)C=C4C5=C(C=CC(=C5)S(=O)(=O)CC6=C(C=CC=C6Cl)Cl)NC4=O

Mechanism of Action

Targets/IC₅₀/Ki	c-Met (Cell-free assay) 9 nM RON (Cell-free assay) 68 nM Flk1 (Cell-free assay) 200 nM
In vitro	PHA-665752 significantly inhibits c-Met kinase activity with K_i of 4 nM, and exhibits >50-fold selectivity for c-Met compared with various tyrosine and serine-threonine kinases. This compound potently inhibits the HGF-stimulated c-Met autophosphorylation with IC50 of 25-50 nM. It also significantly blocks HGF- and c-Met-dependent functions such as cell motility and cell proliferation with IC50 of 40-50 nM and 18-42 nM, respectively. In addition, this chemical potently inhibits HGF-stimulated or constitutive phosphorylation of mediators of downstream of c-Met such as Gab-1, ERK, Akt, STAT3, PLC-γ, and FAK in multiple tumor cell lines. It inhibits cell growth in TPR-MET-transformed BaF3 cells with IC50 of <60 nM, and inhibits constitutive cell motility and migration by 92.5% at 0.2 μM. Inhibition of c-Met by this compound (0.2 μM) also induces cell apoptosis of 33.1% and G1 cell cycle arrest with cells in G1 phase increasing from 42.4% to 77.0%. It can cooperate with rapamycin to inhibit cell growth of TPR-MET-transformed BaF3 cells and non-small cell lung cancer H441 cells.
Kinase Assay	In vitro enzyme assay
Kinase Assay	The c-Met kinase domain GST-fusion protein is used for the c-Met assay. The IC50 value of PHA-665752 for the inhibition of c-Met is based on phosphorylation of kinase peptide substrates or poly-glu-tyr in the presence of ATP and divalent cation (MgCl₂ or MnCl₂ 10-20 mM). The linear range (i.e., the time period over which the rate remains equivalent to the initial rate) is determined for c-Met, and the kinetic measurement and IC50 determination are performed within this range.
In vivo	Administration of PHA-665752 induces a dose-dependent tumor growth inhibition of S114 xenografts by 20 %, 39% and 68%, at dose of 7.5, 15, and 30 mg/kg/day, respectively. This compound treatment significantly reduces the tumor growth of NCI-H69, NCI-H441 and A549 in mouse xenografts by 99%, 75%, and 59%, respectively. It also significantly inhibits angiogenesis by >85%, due to decreasing the production of vascular endothelial growth factor and increasing the production of the angiogenesis inhibitor thrombospondin-1.
References	[1] https://pubmed.ncbi.nlm.nih.gov/14612533/ [2] https://pubmed.ncbi.nlm.nih.gov/15788682/ [3] https://pubmed.ncbi.nlm.nih.gov/17440059/

Applications

Methods	Biomarkers	Images	PMID
Western blot	IDO p-Met / Met / p-Akt / Akt / p-ERK / ERK		27082119
Growth inhibition assay	Cell proliferation		20603611

Tech Support

Handling Instructions

Tel: +1-832-582-8158 Ext:3

If you have any other enquiries, please leave a message.

Frequently Asked Questions

Question 1:
I need to use it for intraperitoneal application in mice. Could you tell me the solvent you use, please?

Answer:
The highest concentration of this compound (S1070) in 4% DMSO+30% PEG 300+5% Tween 80+ddH2O is 5mg/ml. If you want to get higher concentration, the concentration of DMSO and PEG will be higher. For example, it can be dissolved in 8% DMSO+50% PEG 300+5% Tween 80+ddH2O at 10mg/ml clearly.

C1=C0/X	C1:	LOG(C1):
C2=C1/X	C2:	LOG(C2):
C3=C2/X	C3:	LOG(C3):
C4=C3/X	C4:	LOG(C4):
C5=C4/X	C5:	LOG(C5):
C6=C5/X	C6:	LOG(C6):
C7=C6/X	C7:	LOG(C7):
C8=C7/X	C8:	LOG(C8):

PHA-665752 c-Met inhibitor

Chemical Structure

Molecular Weight: 641.61